Phase II study of neo-adjuvant chemotherapy with paclitaxel and cisplatin given every 2 weeks for patients with a resectable squamous cell carcinoma of the esophagus. [electronic resource]
Producer: 20031017Description: 1253-7 p. digitalISSN:- 0923-7534
- Aged
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Carcinoma, Squamous Cell -- drug therapy
- Chemotherapy, Adjuvant
- Cisplatin -- administration & dosage
- Dose-Response Relationship, Drug
- Drug Administration Schedule
- Esophageal Neoplasms -- drug therapy
- Esophagectomy -- methods
- Female
- Humans
- Infusions, Intravenous
- Male
- Middle Aged
- Neoadjuvant Therapy
- Neoplasm Staging
- Paclitaxel -- administration & dosage
- Probability
- Prognosis
- Survival Analysis
- Treatment Outcome
No physical items for this record
Publication Type: Clinical Trial; Clinical Trial, Phase II; Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.